Dimensional Fund Advisors LP Acumen Pharmaceuticals, Inc. Transaction History
Dimensional Fund Advisors LP
- $376 Billion
- Q2 2024
A detailed history of Dimensional Fund Advisors LP transactions in Acumen Pharmaceuticals, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 56,548 shares of ABOS stock, worth $137,411. This represents 0.0% of its overall portfolio holdings.
Number of Shares
56,548
Previous 61,728
8.39%
Holding current value
$137,411
Previous $249,000
45.38%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ABOS
# of Institutions
84Shares Held
41.9MCall Options Held
239KPut Options Held
65.9K-
Ra Capital Management, L.P. Boston, MA14.9MShares$36.3 Million0.54% of portfolio
-
Sands Capital Ventures, LLC Arlington, VA3.42MShares$8.3 Million4.16% of portfolio
-
Franklin Resources Inc San Mateo, CA3.37MShares$8.18 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.3MShares$5.59 Million0.17% of portfolio
-
Black Rock Inc. New York, NY2.16MShares$5.25 Million0.0% of portfolio
About Acumen Pharmaceuticals, Inc.
- Ticker ABOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,503,100
- Market Cap $98.4M
- Description
- Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...